ULTRAGENYX PHARMACEUTICAL INC. (RARE) Gross margin 2017–2018
ULTRAGENYX PHARMACEUTICAL INC. (RARE) gross margin by fiscal year — reported gross profit divided by reported revenue.
97.8%FY2018 · since FY2017: 100.0% → 97.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | 97.8% | -2.2 pp |
| FY2017 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice